Skip to content

MRI for Non-Invasive Imaging in Neonates and Children

MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Young Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02163681
Enrollment
45
Registered
2014-06-16
Start date
2011-01-01
Completion date
2018-07-30
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Bronchopulmonary Dysplasia (BPD), Cystic Fibrosis (CF), Healthy

Brief summary

The purpose of this study is to develop rapid MRI techniques for imaging the lung with hyperpolarized helium-3 gas as an inhaled contrast agent. These techniques will be piloted in adults and older children before testing them in younger children and infants. The purpose is to enable imaging of non-sedated infants by imaging so fast as to freeze motion.

Detailed description

he purpose of this study is to further develop the techniques to permit the imaging of infant lungs with hyperpolarized helium-3 MRI including techniques for acquisition in free breathing infants and infants on a ventilator. We have developed fast imaging techniques and obtained proof-of-concept data in infants as young as 2 months old. Many pediatric lung diseases including CF, bronchopulmonary dysplasia (BPD) and asthma have their origins in infancy so it would be desirable to be able to image infants with hyperpolarized gas MRI. We focused on developing fast imaging techniques to, in essence, freeze lung motion in non-sedated infants. We feel the technique will be more widely adopted if clinically useful images can be obtained without sedating the infant. Some very rapid imaging techniques have been developed for conventional proton MRI for applications such as cardiac MRI that require very short acquisition time. We modified these techniques for use in hyperpolarized gas MRI and developed a technique that permits the acquisition of the entire lung volume of an infant in less than 1 second. These techniques would also be useful for imaging infants who are still on a ventilator with the hope of increasing our understanding of lung development and neonatal lung disease.

Interventions

DRUGHyperpolarized Helium-3 MRI of the chest

hyperpolarized helium-3 is an inhaled gaseous contrast agent for MRI and permits the acquisition of high quality imagined of lung ventilation.

Sponsors

Xemed LLC
CollaboratorINDUSTRY
University of Virginia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Months to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* MRI sequence development (n=40): Healthy subjects and patients with CF, BPD, or asthma will be used in the development of the rapid imaging techniques. These subjects will be age 4 months to 65 years old. Healthy subjects can have no history of chronic respiratory disease. The subjects with CF or asthma must have a physician diagnosis of their respective disease. * Proof-of-Concept Study (n=30): Ten healthy infants,10 infants with CF, and 10 infants with BPD age 4-24 months will be imaged in the proof-of-concept study. Healthy infant must have had an uncomplicated term birth and have no history of chronic respiratory symptoms. The patients with CF must have a physician diagnosis of CF and be at their baseline clinical status on the day of imaging.

Exclusion criteria

* Any condition for which a MRI procedure is contraindicated. * Presence of any non-MRI compatible metallic material in the body, such as pacemakers, metallic clips, etc. * Likelihood of claustrophobia * Chest circumference greater than that of the helium magnetic resonance (MR) coil. * Pregnancy, by report of subject. Clinically in the Department of Radiology at UVA, self report is used when screening patients for MR scans as well as CT scans and fluoroscopy studies. If the subject reports there is any chance of their being pregnant a urine pregnancy test will be performed prior to any imaging.

Design outcomes

Primary

MeasureTime frameDescription
Ventilation Defects as Seen on Hyperpolarized Helium-3 MRIDay 1On hyperpolarized helium-3 MRI, well ventilated areas of the lung appear bright and poorly ventilated areas appear dark. The poorly ventilated areas are called ventilation defects. Human readers looked at the hyperpolarized helium-3 MR images and determined whether the lungs had: No Defects, Small Defects, or Large Defects.

Countries

United States

Participant flow

Participants by arm

ArmCount
Hyperpolarized Helium 3 MRI of the Chest
Using hyperpolarized helium-3 as an inhaled contrast agent for MRI, we will assess the lung ventilation. Hyperpolarized Helium-3 MRI of the chest: hyperpolarized helium-3 is an inhaled gaseous contrast agent for MRI and permits the acquisition of high quality imagined of lung ventilation.
44
Total44

Baseline characteristics

CharacteristicHyperpolarized Helium 3 MRI of the Chest
Age, Continuous5.5 years
STANDARD_DEVIATION 5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
34 Participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
26 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 44
other
Total, other adverse events
5 / 44
serious
Total, serious adverse events
0 / 44

Outcome results

Primary

Ventilation Defects as Seen on Hyperpolarized Helium-3 MRI

On hyperpolarized helium-3 MRI, well ventilated areas of the lung appear bright and poorly ventilated areas appear dark. The poorly ventilated areas are called ventilation defects. Human readers looked at the hyperpolarized helium-3 MR images and determined whether the lungs had: No Defects, Small Defects, or Large Defects.

Time frame: Day 1

Population: 6 of the 44 imaged subjects were part of the technique development and were not included in the data analysis.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Hyperpolarized Helium 3 MRI of the ChestVentilation Defects as Seen on Hyperpolarized Helium-3 MRINo Defects9 Participants
Hyperpolarized Helium 3 MRI of the ChestVentilation Defects as Seen on Hyperpolarized Helium-3 MRISmall Defects13 Participants
Hyperpolarized Helium 3 MRI of the ChestVentilation Defects as Seen on Hyperpolarized Helium-3 MRILarge Defects16 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026